Fabry (-Anderson) disease. E75.21 is a valid billable ICD-10 diagnosis code for Fabry (-Anderson) disease. It is found in the 2019 version of the ICD-10 Clinical Modification (CM) and can be used in all HIPAA-covered transactions from Oct 01, 2018 - Sep 30, 2019.
Degenerative disease of nervous system, unspecified. G31.9 is a billable/specific ICD-10-CM code that can be used to indicate a diagnosis for reimbursement purposes. The 2020 edition of ICD-10-CM G31.9 became effective on October 1, 2019. This is the American ICD-10-CM version of G31.9 - other international versions of ICD-10 G31.9 may differ.
Diagnosis Index entries containing back-references to G31.9: Atrophy, atrophic (of) brain (cortex) (progressive) G31.9 Degeneration, degenerative brain (cortical) (progressive) G31.9 childhood G31.9 Hemiatrophy R68.89 ICD-10-CM Diagnosis Code R68.89
This is the American ICD-10-CM version of G31.9 - other international versions of ICD-10 G31.9 may differ. A disorder of the central nervous system characterized by gradual and progressive loss of neural tissue and neurologic function. Hereditary and sporadic conditions which are characterized by progressive nervous system dysfunction.
81 for Cerebellar ataxia in diseases classified elsewhere is a medical classification as listed by WHO under the range - Diseases of the nervous system .
According to Coding Clinic: “Assign code M16. 0—Bilateral primary osteoarthritis of hip for degenerative changes of hips”. Coding Clinic's rationale is, “ICD-10- CM's Alphabetic Index under “Degeneration, joint disease” instructs “see Osteoarthritis.”
ICD-10 code E75. 21 for Fabry (-Anderson) disease is a medical classification as listed by WHO under the range - Endocrine, nutritional and metabolic diseases .
Fabry disease is a rare inherited disorder of glycosphingolipid (fat) metabolism resulting from the absent or markedly deficient activity of the lysosomal enzyme, α-galactosidase A (α-Gal A). This disorder belongs to a group of diseases known as lysosomal storage disorders.
36 Other intervertebral disc degeneration, lumbar region.
ICD-10 code M15. 9 for Polyosteoarthritis, unspecified is a medical classification as listed by WHO under the range - Arthropathies .
As a result, many neurological deficits may occur in a patient with Fabry disease. These include hemiparesis, vertigo/dizziness, diplopia, dysarthria, nystagmus, nausea/vomiting, headaches, hemiataxia and dysmetria, cerebellar gait ataxia and, very rarely, cerebral haemorrhage [4].
Discussion: Fabry disease is multi-systemic and shares common symptoms with autoimmune rheumatic diseases, for example fatigue (62%) and neuropathic pain (77%).
Without functioning alpha-GAL enzymes, harmful levels of sphingolipids build up in blood vessels and tissues. Fabry disease affects the heart, kidneys, brain, central nervous system and skin. It is an inherited condition passed from parent to child. It's sometimes called Anderson-Fabry disease.
Osteoarthritis is sometimes referred to as degenerative arthritis or degenerative joint disease. It is the most common type of arthritis because it's often caused by the wear and tear on a joint over a lifetime.
722.51 is the correct diagnosis code for thoracic degenerative disc disease. 722.52 is the accurate diagnosis code for DDD of the lumbar or lumbosacral intervertebral disc.
Hereditary and sporadic conditions which are characterized by progressive nervous system dysfunction. These disorders are often associated with atrophy of the affected central or peripheral nervous system structures. Neurologic disorders characterized by progressive nervous system dysfunction and loss of neural tissue.
Degenerative brain disorder. Paraneoplastic cerebellar degeneration. Clinical Information. A disorder of the central nervous system characterized by gradual and progressive loss of neural tissue and neurologic function.
Multiple sulfatase deficiency (also known as "Austin disease," and "Mucosulfatidosis") is a very rare autosomal recessive:561 lysosomal storage disease caused by a deficiency in multiple sulfatase enzymes, or in formylglycine-generating enzyme, which activates sulfatases.:502 It is similar to mucopolysaccharidosis.
The ICD-10-CM Alphabetical Index links the below-listed medical terms to the ICD code E75.21. Click on any term below to browse the alphabetical index.
This is the official approximate match mapping between ICD9 and ICD10, as provided by the General Equivalency mapping crosswalk. This means that while there is no exact mapping between this ICD10 code E75.21 and a single ICD9 code, 272.7 is an approximate match for comparison and conversion purposes.